CWG
IONS icon

C WorldWide Group’s Ionis Pharmaceuticals IONS Stock Holding History

C WorldWide Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29M Hold
366,000
– – 0.7% 22
2026
Q1 		$27.5M Hold
366,000
– – 0.59% 25
2025
Q4 		$29M Sell
366,000
-60,000
-14% -$4.52M 0.51% 26
2025
Q3 		$27.9M Sell
426,000
-24,000
-5% -$1.17M 0.43% 29
2025
Q2 		$17.8M Buy
450,000
+50,000
+13% +$1.64M 0.24% 39
2025
Q1 		$12.1M Hold
400,000
– – 0.15% 57
2024
Q4 		$14M Buy
400,000
+100,000
+33% +$3.74M 0.17% 50
2024
Q3 		$12M Hold
300,000
– – 0.12% 63
2024
Q2 		$14.3M Hold
300,000
– – 0.15% 61
2024
Q1 		$13M Hold
300,000
– – 0.15% 60
2023
Q4 		$15.2M Buy
+300,000
New +$14.4M 0.2% 46
2018
Q4 		– Sell
-5,248
Closed -$271K – 127
2018
Q3 		$271K Buy
5,248
+765
+17% +$35.9K ﹤0.01% 124
2018
Q2 		$187K Hold
4,483
– – ﹤0.01% 124
2018
Q1 		$198K Sell
4,483
-151
-3% -$7.67K ﹤0.01% 119
2017
Q4 		$233K Sell
4,634
-651
-12% -$35.7K ﹤0.01% 114
2017
Q3 		$268K Sell
5,285
-250
-5% -$13.1K ﹤0.01% 119
2017
Q2 		$282K Sell
5,535
-467
-8% -$21.7K ﹤0.01% 117
2017
Q1 		$241K Buy
6,002
+2
+0% +$90 ﹤0.01% 117
2016
Q4 		$287K Sell
6,000
-31,100
-84% -$1.23M 0.01% 110
2016
Q3 		$1.36M Buy
37,100
+2,100
+6% +$65.7K 0.02% 103
2016
Q2 		$815K Sell
35,000
-19,500
-36% -$629K 0.02% 99
2016
Q1 		$2.21M Sell
54,500
-21,560
-28% -$876K 0.04% 67
2015
Q4 		$4.71M Sell
76,060
-15,000
-16% -$809K 0.08% 54
2015
Q3 		$3.68M Buy
91,060
+360
+0.4% +$18.6K 0.06% 64
2015
Q2 		$5.22M Sell
90,700
-7,400
-8% -$471K 0.07% 57
2015
Q1 		$6.25M Sell
98,100
-28,080
-22% -$1.91M 0.09% 50
2014
Q4 		$7.79M Sell
126,180
-61,320
-33% -$3.03M 0.11% 44
2014
Q3 		$7.35M Buy
+187,500
New +$6.64M 0.11% 47

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

C WorldWide Group's IONS Position: Q2 2026 in Review

C WorldWide Group held its Ionis Pharmaceuticals (IONS) position steady in Q2 2026 at 366,000 shares worth $29M. The position accounts for 0.7% of the portfolio, ranked #22.

C WorldWide Group first reported a position in IONS in Q3 2014 and has held it in 28 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • C WorldWide Group held 366,000 shares of Ionis Pharmaceuticals worth $29M as of Q2 2026.
  • C WorldWide Group left its Ionis Pharmaceuticals share count unchanged in Q2 2026.
  • Ionis Pharmaceuticals made up 0.7% of C WorldWide Group's portfolio in Q2 2026, its #22 holding.
  • C WorldWide Group first reported a position in Ionis Pharmaceuticals in Q3 2014 and has held it in 28 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.